Fenmetozole
Fenmetozole
Fenmetozole (pronunciation: fen-met-oh-zole) is a pharmaceutical drug that was developed for the treatment of alcohol dependence and withdrawal.
Etymology
The term "Fenmetozole" is derived from its chemical structure, which includes a phenyl ring (Fen-) and a metazole group (-metozole).
Pharmacology
Fenmetozole acts as an antagonist at the GABA receptors in the brain, which are involved in the sedative effects of alcohol. By blocking these receptors, Fenmetozole can reduce the symptoms of alcohol withdrawal and help to prevent relapse in individuals who are trying to quit drinking.
Related Terms
- Alcohol dependence: A chronic disease characterized by an inability to control or stop drinking despite negative consequences.
- GABA receptors: Receptors in the brain that respond to the neurotransmitter gamma-aminobutyric acid (GABA), which has inhibitory effects on neuronal activity.
- Antagonist: A substance that blocks or inhibits the action of a receptor in the body.
- Withdrawal: The physical and psychological symptoms that occur after stopping or reducing intake of a substance, such as alcohol, that the body has become dependent on.
See Also
- Disulfiram: Another drug used in the treatment of alcohol dependence.
- Naltrexone: A drug used to manage alcohol or opioid dependence.
- Acamprosate: A drug used to manage alcohol dependence.
External links
- Medical encyclopedia article on Fenmetozole
- Wikipedia's article - Fenmetozole
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski